Pfizer Gets Partial Win In Sandoz Generic Bladder Drug Row
A Delaware federal judge ruled Tuesday that Sandoz Inc. infringed two of five patents licensed by Pfizer Inc. protecting the latter's Toviaz overactive bladder treatment, saying the testimony of Pfizer's expert...To view the full article, register now.
Already a subscriber? Click here to view full article